• Standing up against Trump’s attack on birth control
    October 13, 2017
    Standing up against Trump’s attack on birth control
    Last week the Trump Administration released two new rules to dismantle the Affordable Care Act (ACA)’s contraception coverage, effective immediately. Unless the courts stop them, millions of employers will have the right to deny their employees birth control coverage for any reason—or no reason at all. What has the contraceptive coverage rule meant for women and ...
  • Let Women Get the Abortion Pill (Mifepristone) from Pharmacies
    October 6, 2017
    Let Women Get the Abortion Pill (Mifepristone) from Pharmacies
    In exciting news this week, the American Civil Liberties Union (ACLU) filed a lawsuit against the FDA in an effort to remove medically unnecessary barriers and make medication abortion more accessible. Since its approval in France in 1987, scientists and doctors have known that medication abortion, also called abortion with pills, is a safe and ...
  • Graham-Cassidy: the Most Radical Trumpcare Bill Yet
    September 20, 2017
    Graham-Cassidy: the Most Radical Trumpcare Bill Yet
    Senate Republicans are making one last push to repeal the Affordable Care Act (ACA) and gut Medicaid and their latest Trumpcare bill known as Graham-Cassidy is the most radical one yet! Pushed by Senators Lindsey Graham (R-SC) and Bill Cassidy (R-LA), the bill repeals the ACA’s consumer protections, allowing insurance companies to once again discriminate against ...
  • FDA Approvals: On a Fast-Track to Disaster
    September 14, 2017
    FDA Approvals: On a Fast-Track to Disaster
    By Caila Brander, NWHN Policy Fellow Most of us want to be confident when we start a newly prescribed treatment that the medication we take will improve the ailment we seek to treat. We believe that our drugs have been tested and proven effective. We assume that the U.S. Food and Drug Administration (FDA) verifies that ...
  • The Heated Battle for Healthcare
    August 16, 2017
    The Heated Battle for Healthcare
    By Allyson Paiewonsky, NWHN Communications Intern On a hot June day in D.C, I headed to a rally on Capitol Hill to save healthcare with three other summer interns from the National Women’s Health Network. We saw group of protesters waving signs urging the Senate to protect the Affordable Care Act (ACA) and save Medicaid. As ...
  • What is the Gun Gag Rule, and Why Should it Matter to You?
    July 7, 2017
    By Barbara Gold, MD, FAAP Pediatricians ask lots of questions relevant to children’s health and well-being. Do you have a smoker in the house; is there a swimming pool; do you insist on the use of an infant/toddler car seat or a seat belt? Do you wear a seat belt? Does your child wear a bike ...
  • Trump’s FDA and PenceWorld: The Battles Ahead
    July 7, 2017
    “The president has left his stamp on government in ways that could outlast him, but the NWHN will be there to shine a spotlight.” As I write this, it’s impossible to know what is going to become of Donald Trump, currently mired in controversy. Each day brings new scandal and, with it, the possibility that he ...
  • An NWHN Event to Remember!
    June 20, 2017
    An NWHN Event to Remember!
    Last week, The National Women’s Health Network was proud to host the 10th Annual Barbara Seaman Awards for Activism in Women’s Health. Supporters and members of the National Women’s Health Network celebrated the Network’s recent achievements and recognized the work of two remarkable women, Susan F. Wood and Renee Bracey Sherman. Board Member, Zipatly Mendoza was ...
  • Whose Right to Free Speech? How Pharma is Co-opting the First Amendment for Profit
    June 14, 2017
    Whose Right to Free Speech? How Pharma is Co-opting the First Amendment for Profit
    By Caila Brander, NWHN Policy Fellow The First Amendment’s protection of free speech is a cornerstone of individual freedom in the United States. However, not all speech is equally protected under the Constitution. Speech that threatens the safety and wellbeing of others can be limited under longstanding legal precedent. Similarly, for most of our nation’s history, ...
  • What You Should Know about Tymlos (Abaloparatide) for Osteoporosis
    May 20, 2017
    What You Should Know about Tymlos (Abaloparatide) for Osteoporosis
    By Caila Brander, NWHN Policy Fellow There’s a new kid in town when it comes to osteoporosis drugs. Meet abaloparatide, brand name Tymlos, which was approved by the FDA on April 28, 2017. If you haven’t heard of it yet, you likely will soon, as manufacturer Radius Health is intent on marketing it until it’s also ...